Product Information
BUSPIRONE HCL 30 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1187 per EA under NDC 59651039360. Its NADAC has been published 277 times since May 5, 2021.
FDA first approved this application on Feb 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651039360
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078246FDA Approved
2/27/2009
TE Code
AB
On Market Since
2/21/2020
Price Statistics
The NADAC for BUSPIRONE HCL 30 MG TABLET has been published 277 times since May 5, 2021, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1187 per EA |
|---|---|
| All-time high | $0.2408 (May 12, 2021) |
| All-time low | $0.0971 (May 22, 2024) |
| 52-week high | $0.1235 |
| 52-week low | $0.1098 |
| Median price | $0.1320 |
| Average price | $0.1471 |
| Largest weekly change | +36.0% (Jun 19, 2024) |
| Weeks tracked | 277 |
| Tracking since | May 5, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUSPIRONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 30 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1187 per EA (NDC 59651039360), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 30 MG TABLET has declined 50.7%. It has been tracked across 277 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 30 MG TABLET?
Since May 5, 2021, the NADAC for BUSPIRONE HCL 30 MG TABLET has ranged from a low of $0.0971 (May 22, 2024) to a high of $0.2408 (May 12, 2021), with a median of $0.1320 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BUSPIRONE HCL 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUSPIRONE HCL 30 MG TABLET?
BUSPIRONE HCL 30 MG TABLET (NDC 59651039360) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.